Epigenomics AG (ECX) - Financials, balance sheet (quarterly)

1.13000 EUR

0.25

18.12%

Last update Apr 29, 8:23 AM CEST

Market closed

Day range

1.13000

Previous close

1.38000

Open

1.13000

Access this stock data via API

Epigenomics AG

1.13

0.25

18.12%

Financials

Balance sheet

Fiscal date	Jun 2023	Mar 2023	Dec 2022	Sep 2022
Total assets	4.2M	11.1M	15.9M	19.0M
Current assets	4.2M	7.6M	10.8M	16.9M
Cash	—	—	10.0M	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	3.6M	6.9M	10.0M	15.8M
Other short term investments	—	—	—	—
Accounts receivable	209K	82K	42K	128K
Other receivables	3K	—	48K	—
Inventory	0	0	61K	217K
Prepaid assets	237K	—	234K	—
Restricted cash	—	—	90K	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	33K	655K	40K	775K
Non current assets	60K	3.5M	5.0M	2.1M
Properties	6K	—	3.2M	—
Land and improvements	—	—	—	—
Machinery furniture equipment	0	—	1.3M	—
Construction in progress	—	—	—	—
Leases	—	—	—	—
Accumulated depreciation	—	—	-2.5M	—
Goodwill	54K	2.9M	3.0M	73K
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	54K	—	3.0M	—
Investments and advances	—	—	—	—
Other non current assets	—	—	—	1K
Total liabilities	2.3M	6.5M	5.7M	5.0M
Current liabilities	2.2M	6.3M	5.1M	4.4M
Accounts payable	522K	3.0M	3.5M	1.1M
Accrued expenses	—	—	—	—
Short term debt	232K	255K	324K	337K
Deferred revenue	—	—	—	—
Tax payable	73K	—	59K	—
Pensions	—	—	—	—
Other current liabilities	53K	2.0M	65K	872K
Non current liabilities	158K	243K	606K	678K
Long term provisions	34K	59K	89K	49K
Long term debt	124K	184K	517K	629K
Provision for risks and charges	—	—	—	—
Deferred liabilities	—	—	—	—
Derivative product liabilities	—	—	—	—
Other non current liabilities	—	—	—	—
Shareholders equity
Common stock	4.3M	4.3M	4.1M	16.4M
Retained earnings	-104.6M	-102.0M	-96.4M	-98.7M
Other shareholders equity	—	—	—	—
Total shareholders equity	1.9M	4.5M	10.2M	13.9M
Additional paid in capital	102.2M	102.2M	102.4M	98.9M
Treasury stock	—	—	—	—
Minority interest	—	—	—	—